We serve Chemical Name:benzyl N-(4-methylpiperidin-4-yl)carbamate,hydrochloride CAS:236406-15-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:benzyl N-(4-methylpiperidin-4-yl)carbamate,hydrochloride
CAS.NO:236406-15-8
Synonyms:4-Benzyloxycarbonylamino-4-methyl-piperidine hydrochloride;4-(CBZ-AMINO)-4-METHYLPIPERIDINE HCL;phenylmethyl (4-methyl-4-piperidinyl)carbamate;4-methylpiperidin-4-yl-carbamic acid benzyl ester;4-BENZYLOXYCARBONYLAMINO-4-METHYL-PIPERIDINE;benzyl (4-methylpiperidin-4-yl)carbamate
Molecular Formula:C14H20N2O2
Molecular Weight:248.32100
HS Code:2933399090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:394.9ºC at 760mmHg
Density:1.11g/cm3
Index of Refraction:1.552
PSA:50.36000
Exact Mass:248.15200
LogP:2.77460
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 4-Benzyloxycarbonylamino-4-methyl-piperidine hydrochloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,benzyl (4-methylpiperidin-4-yl)carbamate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,benzyl (4-methylpiperidin-4-yl)carbamate Use and application,phenylmethyl (4-methyl-4-piperidinyl)carbamate technical grade,usp/ep/jp grade.
Related News: EMA said the drug can help improve the respiratory function of Pompe disease patients, and the most common side effects include hypersensitivity (including anaphylaxis) and infusion-associated reactions. 2,4-dihydro-1H-pyrido[2,3-e][1,2,4]triazin-3-one manufacturers MSD – known as Merck in the US and Canada – is jointly developing Verquvo with Bayer. While MSD hold the commercial rights to the heart failure med in the US, Bayer has the exclusive commercial rights in the rest of the world. (3-benzylphenyl)hydrazine suppliers EMA said the drug can help improve the respiratory function of Pompe disease patients, and the most common side effects include hypersensitivity (including anaphylaxis) and infusion-associated reactions. 3-(4-Methylphenyl)-1H-pyrazole vendor & factory MSD – known as Merck in the US and Canada – is jointly developing Verquvo with Bayer. While MSD hold the commercial rights to the heart failure med in the US, Bayer has the exclusive commercial rights in the rest of the world.,EMA said the drug can help improve the respiratory function of Pompe disease patients, and the most common side effects include hypersensitivity (including anaphylaxis) and infusion-associated reactions.
